VERACYTE
About
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees to not only make a meaningful impact on the lives of patients, but to also learn and grow within a purpose driven environment. This is what we call the Veracyte way – it’s about how we work together, guided by our values, to give clinicians the insights they need to help pati...
Updates & Highlights
Why Veracyte Stock Is Skyrocketing Higher This Week
Why Veracyte Stock Is Skyrocketing Higher This Week
AOL.com · 1 day ago
FMR LLC holds 8.06M Veracyte (VCYT) shares, representing 10.1%
FMR LLC holds 8.06M Veracyte (VCYT) shares, representing 10.1%
Stock Titan · 1 day ago
Veracyte (VCYT) CFO trades shares as RSUs vest and 10b5-1 plan executes
Veracyte (VCYT) CFO trades shares as RSUs vest and 10b5-1 plan executes
Stock Titan · 2 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Veracyte?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentWhy Veracyte Stock Is Skyrocketing Higher This Week
Why Veracyte Stock Is Skyrocketing Higher This Week
AOL.com · 1 day ago
FMR LLC holds 8.06M Veracyte (VCYT) shares, representing 10.1%
FMR LLC holds 8.06M Veracyte (VCYT) shares, representing 10.1%
Stock Titan · 1 day ago
Veracyte (VCYT) CFO trades shares as RSUs vest and 10b5-1 plan executes
Veracyte (VCYT) CFO trades shares as RSUs vest and 10b5-1 plan executes
Stock Titan · 2 days ago
Veracyte CEO exercises options, sells 138K shares | VCYT Insider Trading
Veracyte CEO exercises options, sells 138K shares | VCYT Insider Trading
Stock Titan · 2 days ago
Veracyte (VCYT) CCO sells 13,975 shares under 10b5-1 plan, keeps 132K
Veracyte (VCYT) CCO sells 13,975 shares under 10b5-1 plan, keeps 132K
Stock Titan · 2 days ago
Veracyte (VCYT) CSMO has shares withheld for RSU tax obligations
Veracyte (VCYT) CSMO has shares withheld for RSU tax obligations
Stock Titan · 2 days ago
Veracyte (VCYT) EVP records 3,176-share sale and tax withholding moves
Veracyte (VCYT) EVP records 3,176-share sale and tax withholding moves
Stock Titan · 2 days ago
Veracyte (VCYT) CAO reports 1,361 shares withheld for RSU tax obligations
Veracyte (VCYT) CAO reports 1,361 shares withheld for RSU tax obligations
Stock Titan · 2 days ago
Veracyte global chief commercial off sells $699,732 in stock
Veracyte global chief commercial off sells $699,732 in stock
Investing.com · 2 days ago
Veracyte CFO Rebecca Chambers sells $177,082 in company stock
Veracyte CFO Rebecca Chambers sells $177,082 in company stock
Investing.com · 2 days ago
Veracyte EVP Annie McGuire sells $158k in company stock
Veracyte EVP Annie McGuire sells $158k in company stock
Investing.com · 2 days ago
Veracyte CEO Marc Stapley sells $6.9m in company shares
Veracyte CEO Marc Stapley sells $6.9m in company shares
Investing.com · 2 days ago
[144] VERACYTE, INC. SEC Filing
[144] VERACYTE, INC. SEC Filing
Stock Titan · 2 days ago
VCYT Stock Price, Quote & Chart | VERACYTE INC (NASDAQ:VCYT)
VCYT Stock Price, Quote & Chart | VERACYTE INC (NASDAQ:VCYT)
ChartMill · 2 days ago
Veracyte (VCYT) Is Up 9.4% After New Phase III Data Validates Prosigna Chemotherapy-Guidance Role – Has The Bull Case Changed?
Veracyte (VCYT) Is Up 9.4% After New Phase III Data Validates Prosigna Chemotherapy-Guidance Role – Has The Bull Case Changed?
simplywall.st · 2 days ago
How Veracyte (VCYT) Investors Can Read The Latest Unchanged Analyst Call
How Veracyte (VCYT) Investors Can Read The Latest Unchanged Analyst Call
Yahoo Finance · 2 days ago
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
Yahoo Finance · 2 days ago
Veracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and Prostate Cancer - Slideshow (NASDAQ:VCYT) 2026-06-03
Veracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and Prostate Cancer - Slideshow (NASDAQ:VCYT) 2026-06-03
Seeking Alpha · 3 days ago
Veracyte Launches Test Identifying Breast Cancer Patients Who Don’t Need Chemo
Veracyte Launches Test Identifying Breast Cancer Patients Who Don’t Need Chemo
Inside Precision Medicine · 3 days ago
Veracyte stock price target maintained at $42 by Canaccord on study results
Veracyte stock price target maintained at $42 by Canaccord on study results
Investing.com · 4 days ago